Drug firms have already agreed to significant price cuts in hope that this would be offset by the influx of customers from the individual mandate being passed, reports CNBC's Seema Mody.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT